{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:08:53Z","timestamp":1791493733548,"version":"4.3.4"},"reference-count":40,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1136\/bjophthalmol-2014-306433","type":"journal-article","created":{"date-parts":[[2015,2,12]],"date-time":"2015-02-12T23:05:15Z","timestamp":1423782315000},"page":"3-8","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":37,"title":["Cornea verticillata supports a diagnosis of Fabry disease in non-classical phenotypes: results from the Dutch cohort and a systematic review"],"prefix":"10.1136","volume":"100","author":[{"given":"Linda","family":"van der Tol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marije L","family":"Sminia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla E M","family":"Hollak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke","family":"Biegstraaten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2015,2,12]]},"reference":[{"key":"key-10.1136\/bjophthalmol-2014-306433-1","first-page":"3733","article-title":"Chapter 150: \u03b1-Galactosidase A deficiency: Fabry disease","volume-title":"The Online Metabolic and Molecular bases of Inherited Disease","author":"Desnick","year":"2007"},{"key":"key-10.1136\/bjophthalmol-2014-306433-2","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders","volume":"281","author":"Meikle","year":"1999","journal-title":"JAMA"},{"key":"key-10.1136\/bjophthalmol-2014-306433-3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s004399900075","article-title":"The frequency of lysosomal storage diseases in The Netherlands","volume":"105","author":"Poorthuis","year":"1999","journal-title":"Hum Genet"},{"key":"key-10.1136\/bjophthalmol-2014-306433-4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jmedgenet-2013-101857","article-title":"A systematic review on screening for Fabry disease: prevalence of individuals with genetic variants of unknown significance","volume":"51","author":"van der Tol","year":"2014","journal-title":"J Med Genet"},{"key":"key-10.1136\/bjophthalmol-2014-306433-5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/8904_2014_342","article-title":"Uncertain diagnosis of fabry disease in patients with neuropathic pain, angiokeratoma or cornea verticillata: consensus on the approach to diagnosis and follow-up","volume":"17","author":"van der Tol","year":"2014","journal-title":"JIMD Rep"},{"key":"key-10.1136\/bjophthalmol-2014-306433-6","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/01.icu.0000143688.45232.15","article-title":"Drug-induced corneal complications","volume":"15","author":"Hollander","year":"2004","journal-title":"Curr Opin Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2014-306433-7","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ijcard.2014.09.001","article-title":"Uncertain diagnosis of Fabry disease: Consensus recommendation on diagnosis in adults with left ventricular hypertrophy and genetic variants of unknown significance","volume":"177","author":"Smid","year":"2014","journal-title":"Int J Cardiol"},{"key":"key-10.1136\/bjophthalmol-2014-306433-8","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S1096-7192(03)00136-7","article-title":"Fabry disease: D313Y is an alpha-galactosidase A sequence variant that causes pseudodeficient activity in plasma","volume":"80","author":"Froissart","year":"2003","journal-title":"Mol Genet Metab"},{"key":"key-10.1136\/bjophthalmol-2014-306433-9","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/humu.10275","article-title":"Fabry disease: characterization of alpha-galactosidase A double mutations and the D313Y plasma enzyme pseudodeficiency allele","volume":"22","author":"Yasuda","year":"2003","journal-title":"Hum Mutat"},{"key":"key-10.1136\/bjophthalmol-2014-306433-10","first-page":"119","article-title":"Approximate is better than \u201cexact\u201d for interval estimation of binomial proportions","volume":"52","author":"Agresti","year":"1998","journal-title":"Am Stat"},{"key":"key-10.1136\/bjophthalmol-2014-306433-11","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1023\/A:1012993305223","article-title":"Anderson-Fabry disease: clinical manifestations of disease in female heterozygotes","volume":"24","author":"Whybra","year":"2001","journal-title":"J Inherit Metab Dis"},{"key":"key-10.1136\/bjophthalmol-2014-306433-12","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1001\/archopht.1979.01020010327008","article-title":"The ocular manifestations in Fabry's disease","volume":"97","author":"Sher","year":"1979","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2014-306433-13","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1136\/bjo.2009.176651","article-title":"Fabry disease in children: correlation between ocular manifestations, genotype and systemic clinical severity","volume":"94","author":"Allen","year":"2010","journal-title":"Br J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2014-306433-14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1157\/13063178","article-title":"Fabry's disease in Spain. Study of 24 cases","volume":"123","author":"Barba Romero","year":"2004","journal-title":"Med Clin"},{"key":"key-10.1136\/bjophthalmol-2014-306433-15","first-page":"373","article-title":"[Ophthalmic manifestations in Mexican patients with Fabry disease]","volume":"87","author":"Beltran-Becerra","year":"2012","journal-title":"Arch Soc Esp Oftalmol"},{"key":"key-10.1136\/bjophthalmol-2014-306433-16","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1399-0004.2012.01947.x","article-title":"Fabry disease in children: agalsidase-beta enzyme replacement therapy","volume":"83","author":"Borgwardt","year":"2013","journal-title":"Clin Genet"},{"key":"key-10.1136\/bjophthalmol-2014-306433-17","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3346\/jkms.2008.23.2.243","article-title":"Short-term efficacy of enzyme replacement therapy in Korean patients with Fabry disease","volume":"23","author":"Choi","year":"2008","journal-title":"J Korean Med Sci"},{"key":"key-10.1136\/bjophthalmol-2014-306433-18","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00417-008-0962-9","article-title":"The microstructure of cornea verticillata in Fabry disease and amiodarone-induced keratopathy: a confocal laser-scanning microscopy study","volume":"247","author":"Falke","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2014-306433-19","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/01.md.0000178976.62537.6b","article-title":"The relationship of vascular glycolipid storage to clinical manifestations of Fabry disease: A cross-sectional study of a large cohort of clinically affected heterozygous women","volume":"84","author":"Gupta","year":"2005","journal-title":"Medicine"},{"key":"key-10.1136\/bjophthalmol-2014-306433-20","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/ijcp.12016","article-title":"Multidimensional analysis of clinical symptoms in patients with Fabry's disease","volume":"67","author":"Kaminsky","year":"2013","journal-title":"Int J Clin Pract"},{"key":"key-10.1136\/bjophthalmol-2014-306433-21","article-title":"Clinical manifestations and natural history of Japanese heterozygous females with Fabry disease","author":"Kobayashi","journal-title":"J Inherit Metab Dis"},{"key":"key-10.1136\/bjophthalmol-2014-306433-22","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s10545-010-9166-7","article-title":"Enzyme assay and clinical assessment in subjects with a Chinese hotspot late-onset Fabry mutation (IVS4 + 919G\u2013>A)","volume":"33","author":"Lin","year":"2010","journal-title":"J Inherit Metab Dis"},{"key":"key-10.1136\/bjophthalmol-2014-306433-23","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1442-9071.2005.00990.x","article-title":"Ophthalmological manifestations of Fabry disease: a survey of patients at the Royal Melbourne Fabry Disease Treatment Centre","volume":"33","author":"Nguyen","year":"2005","journal-title":"Clin Experiment Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2014-306433-24","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1076\/opge.24.3.129.15609","article-title":"Ocular manifestations in Fabry disease: a survey of 32 hemizygous male patients","volume":"24","author":"Orssaud","year":"2003","journal-title":"Ophthalmic Genet"},{"key":"key-10.1136\/bjophthalmol-2014-306433-25","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3109\/13816810903148004","article-title":"Subclinical optic neuropathy in Fabry disease","volume":"30","author":"Pitz","year":"2009","journal-title":"Ophthalmic Genet"},{"key":"key-10.1136\/bjophthalmol-2014-306433-26","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1556\/OH.2007.28086","article-title":"[Molecular pathology and clinical manifestations of Fabry disease]","volume":"148","author":"Rakoczi","year":"2007","journal-title":"Orv Hetil"},{"key":"key-10.1136\/bjophthalmol-2014-306433-27","first-page":"37","article-title":"Evaluation of patients with Fabry disease in Argentina","volume":"70","author":"Reisin","year":"2010","journal-title":"Medicina"},{"key":"key-10.1136\/bjophthalmol-2014-306433-28","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1542\/peds.2004-1678","article-title":"Pediatric Fabry disease","volume":"115","author":"Ries","year":"2005","journal-title":"Pediatrics"},{"key":"key-10.1136\/bjophthalmol-2014-306433-29","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00431-003-1299-3","article-title":"The early clinical phenotype of Fabry disease: a study on 35 European children and adolescents","volume":"162","author":"Ries","year":"2003","journal-title":"Eur J Pediatr"},{"key":"key-10.1136\/bjophthalmol-2014-306433-30","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1111\/j.1755-3768.2012.02576.x","article-title":"Computer assisted evaluation of retinal vessels tortuosity in Fabry disease","volume":"91","author":"Sodi","year":"2013","journal-title":"Acta Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2014-306433-31","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1053\/j.ajkd.2007.12.032","article-title":"Renal biopsy findings in children and adolescents with Fabry disease and minimal albuminuria","volume":"51","author":"Tondel","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"key-10.1136\/bjophthalmol-2014-306433-32","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.clineuro.2012.11.003","article-title":"Phenotypical characterization of alpha-galactosidase A gene mutations identified in a large Fabry disease screening program in stroke in the young","volume":"115","author":"De Brabander","year":"2013","journal-title":"Clin Neurol Neurosurg"},{"key":"key-10.1136\/bjophthalmol-2014-306433-33","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1056\/NEJM199508033330504","article-title":"An atypical variant of Fabry's disease in men with left ventricular hypertrophy","volume":"333","author":"Nakao","year":"1995","journal-title":"N Engl J Med"},{"key":"key-10.1136\/bjophthalmol-2014-306433-34","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s10545-007-0521-2","article-title":"Fabry disease: baseline medical characteristics of a cohort of 1765 males and females in the Fabry Registry","volume":"30","author":"Eng","year":"2007","journal-title":"J Inherit Metab Dis"},{"key":"key-10.1136\/bjophthalmol-2014-306433-35","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1136\/bjo.2006.100602","article-title":"Ocular manifestations of Fabry's disease: data from the Fabry Outcome Survey","volume":"91","author":"Sodi","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2014-306433-36","article-title":"Diagnostic dilemmas in Fabry disease: a case series study on GLA mutations of unknown clinical significance","author":"Smid","journal-title":"Clin Genet"},{"key":"key-10.1136\/bjophthalmol-2014-306433-37","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1001\/archopht.1965.00970040762005","article-title":"Fabry's disease. Its ocular manifestations","volume":"74","author":"Spaeth","year":"1965","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2014-306433-38","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1159\/000322558","article-title":"Basilar artery diameter is a potential screening tool for Fabry disease in young stroke patients","volume":"31","author":"Fellgiebel","year":"2011","journal-title":"Cerebrovasc Dis"},{"key":"key-10.1136\/bjophthalmol-2014-306433-39","doi-asserted-by":"crossref","first-page":"e87054","DOI":"10.1371\/journal.pone.0087054","article-title":"Increased arterial diameters in the posterior cerebral circulation in men with Fabry disease","volume":"9","author":"\u00dc\u00e7eyler","year":"2014","journal-title":"PLoS ONE"},{"key":"key-10.1136\/bjophthalmol-2014-306433-40","unstructured":"van der Tol L, \u00dc\u00e7eyler N, Burlina A, et al. The value of specific brain imaging characteristics in the diagnosis of Fabry disease. 2014; submitted."}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjophthalmol-2014-306433","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T04:49:43Z","timestamp":1601095783000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjophthalmol-2014-306433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,12]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,12,21]]},"published-print":{"date-parts":[[2016,1]]}},"alternative-id":["10.1136\/bjophthalmol-2014-306433"],"URL":"https:\/\/doi.org\/10.1136\/bjophthalmol-2014-306433","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,12]]}}}